Lek, a Sandoz company

Committed to health for more than 75 years

We consolidate our presence in Slovenia through continuous investment in development and production capacity. We build a stimulating, competitive and supportive work environment. We strengthen our role as a catalyst for the development of the pharmaceutical industry in Slovenia.

Sustainability Report 2021 Lek d.d.

See how we achieved our responsible role in society and increased the efficient use of natural resources.

Our anniversaries

In 2021, we celebrated 75 years since the founding of Lek, 25 years since the founding of Novartis and 15 years since the approval of the first biosimilar developed by Sandoz.

The Novartis Commitment to Patients and Caregivers

Only by working together can we improve outcomes for patients and change the practice of medicine.

9. 3. 2023

Signing of Memorandum of Understanding for advanced production center for biosimilars at Lek in Lendava

2. 2. 2023

A year of record high investments by Novartis in Slovenia paved by innovation and digitalization

17. 1. 2023

Novartis in Slovenia once again impresses with its P&O excellence and wins the "Top Employer" certificate for the third time

20. 12. 2022

New website rakdojk.si – support on the journey of breast cancer patients